Tiziana Life Sciences Ltd.: Tiziana Life Sciences to Host KOL Webinar on Foralumab in Non-Active Secondary Progressive Multiple Sclerosis (SPMS)

Webinar to take place on Monday, June 5, 2023 at 12:30 PM ETNEW YORK, May 25, 2023) ("Tiziana" or the "Company"), a biotechnology company developing breakthrough immunomodulation therapies via novel routes

Related Keywords

United States ,American ,Paul Spencer ,Howardl Weiner ,Gewinn Nur ,Robertl Kroc ,Neuromyelitis Optica ,Howard Weiner ,Irina Koffler ,Amd Co ,Award For Outstanding Research Achievement ,Tiziana Life Sciences ,American Academy Of Neurology ,David Koetser Foundation For Brain Research ,Access Program ,Harvard Medical School ,John Dystel Prize For Multiple Sclerosis Research ,Tiziana Life Sciences Ltd ,Founder Of The Partners Multiple Sclerosis Center ,Lifesci Advisors ,Partners Multiple Sclerosis Center At Brigham ,Business Development ,Ann Romney Center ,Neurologic Diseases ,Mass General Brigham Healthcare System ,Expanded Access Program ,Partners Multiple Sclerosis Center ,Show Science ,Medical School ,Neurology Endowed ,John Dystel Prize ,Multiple Sclerosis Research ,American Academy ,David Koetser Memorial Prize ,David Koetser Foundation ,Outstanding Research Achievement ,Nature Biotechnology Scicaf ,Life Sciences ,Investor Relations ,Sci Advisors ,Tiziana ,Life ,Ciences ,Most ,Ebinar ,Foralumab ,Ctive ,Secondary ,Progressive ,Multiple ,Clerosis ,Pms ,